Program leverages personalized care delivery to help members with
hemophilia live healthy, vibrant lives.
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Apr. 17, 2018--
Health, Inc. (NASDAQ: MGLN) today announced that Magellan Rx
Management, the pharmacy benefit management division of the company, has
released results from the first six months of its hemophilia management
program launched in collaboration with Health New England, a non-profit
health plan serving the commercial, Medicaid and Medicare markets.
Hemophilia is a rare genetic bleeding disorder, for which treatment is
expensive and difficult to manage. The average annual cost per member
with severe hemophilia can exceed $250,000, and may be upward of $1
million for members who have developed inhibitors. Personalized care
programs for patients with hemophilia aim to reduce unnecessary costs
while improving the overall quality of care.
“As April 17 is World Hemophilia Day, we’re excited to bring hemophilia
care into the spotlight and highlight the early results achieved with
Health New England through our hemophilia management program,” said
Haita Makanji, vice president, clinical specialty solutions at Magellan
Rx Management. “Through personalized interventions, we’re able to better
determine the individual member needs and coordinate across key
stakeholders to deliver a truly personalized care program that ensures
members with hemophilia receive best-in-class care and achieve optimal
Since launching the hemophilia management program in August 2017,
Magellan Rx Management and Health New England have standardized care
across various stakeholders without compromising patient outcomes,
Optimized doses through assay management or pharmacokinetic (PK)
testing in 50 percent of members
Reduced average assay dispensed in prophylaxis patients from 5 percent
to 1 percent, reducing the potential for waste
No breakthrough bleeding reported from members who had a dose reduction
“In the past eight months of collaboration with Magellan, we’ve achieved
our goals of ensuring high quality of care for members with hemophilia
while minimizing potential waste created through excess dispensing and
inappropriate dosing,” said Andrew J. Colby, R.Ph, MBA, Health New
England's pharmacy director. “By announcing our hemophilia management
program results on World Hemophilia Day, we hope to raise the profile of
this condition and look to continue to make strides in standardizing
best treatment practices to benefit members across the country.”
The hemophilia management program aims to enhance overall quality and
personalization of hemophilia care by coordinating with prescribers,
members and pharmacies while reducing unnecessary costs. Key elements
Helping payers analyze information related to member bleed history and
hemophilia treatment patterns.
Standardizing dispensing and optimal dose protocols to promote best
practices and improve transparency in hemophilia care.
Updating policies to encourage individualized treatment regimens based
on member-specific metabolic factors.
About Health New England: Based in Springfield, Mass., Health New
England is a non-profit health plan serving members in Massachusetts and
Connecticut. A wholly-owned subsidiary of Baystate Health, Health New
England offers a range of health care plans in the commercial, Medicaid
and Medicare markets. For more information, visit healthnewengland.org.
About Magellan Rx Management: Magellan Rx Management is a
full-service PBM that expands beyond traditional core services to help
its customers and members solve complex pharmacy challenges by
connecting them to the people, technology and information they need to
make smarter healthcare decisions. Magellan Rx Management is leading the
next evolution of PBMs by using a value-driven approach that moves past
the traditional volume-focused thinking to deliver true value-driven
solutions, including targeted clinical programs, powerful member and
provider engagement strategies, advanced analytics and expert specialty
pharmacy management capabilities.
About Magellan Health: Magellan
Health, Inc. is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through technology,
while remaining focused on the critical personal relationships that are
necessary to achieve a healthy, vibrant life. Magellan's customers
include health plans and other managed care organizations, employers,
labor unions, various military and governmental agencies and third-party
administrators. For more information, visit MagellanHealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180417005266/en/
Source: Magellan Health, Inc.
Magellan Health, Inc.
Joe Bogdan, 860-507-1910